Viewing Study NCT01201993


Ignite Creation Date: 2025-12-25 @ 1:22 AM
Ignite Modification Date: 2025-12-25 @ 11:31 PM
Study NCT ID: NCT01201993
Status: SUSPENDED
Last Update Posted: 2011-06-21
First Post: 2010-08-17
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Clinical and Laboratory Characteristics of Patients Admitted With Syncope; Diagnosis and Follow up After These Patients
Sponsor: Carmel Medical Center
Organization:

Study Overview

Official Title: Observational Study Following After Patients Admitted With Syncope
Status: SUSPENDED
Status Verified Date: 2010-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The investigators hypothesis is that a significant number of patients may remain without specific cause and have recurrent syncope with its associated physical and mental morbidity.
Detailed Description: 1. Patients with diagnosis of syncope who were admitted to the medical ward will be interviewed and their charts reviewed to rule in or out the diagnosis of syncope.
2. Assess physical and mental injury as a result of syncope.
3. The lab workup will be documented including;

1. \- Routine blood tests.

* troponin level.
2. \- ECG.

* Echocardiogram
* Brain CT.
* EEG.
* U/S doppler of carotids.
* Tilt tests.
4. At the time of diagnosis the final diagnosis will be documented including recommendations for patients to prevent syncope after discharge.
5. Follow up after patients by phone verifying recurrence of syncope and resulting physical and or mental injury if any.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: